11 results
10-K
2023 FY
MIRA
Mira Pharmaceuticals Inc
1 Apr 24
Annual report
7:00am
, pandemics, epidemics, and outbreaks could significantly disrupt our pre-clinical studies and clinical trials, commercialization efforts, supply chain, regulatory … compliance with Good Manufacturing Practices (GMP) standards. Integral to this stage is the development of a robust supply chain strategy to manage
424B4
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus supplement with pricing info
1:01pm
and clinical trials, commercialization efforts, supply chain, regulatory and clinical development activities, and other business operations, in addition … of the COVID-19 pandemic as a result of the current and potential future impacts on our commercialization efforts, supply chain, regulatory
424B1
MIRA
Mira Pharmaceuticals Inc
4 Aug 23
Prospectus with pricing info
12:59pm
coronavirus (“COVID-19”), which could significantly disrupt our pre-clinical studies and clinical trials, commercialization efforts, supply chain, regulatory … pandemic as a result of the current and potential future impacts on our commercialization efforts, supply chain, regulatory and clinical development
S-1
h1m9k1k
29 Jun 23
IPO registration
4:39pm
DRS/A
hzi0c
8 Jun 23
Draft registration statement (amended)
12:00am
DRS/A
56elj 76s
2 May 23
Draft registration statement (amended)
12:00am
DRS
zy51q2b1
29 Jun 22
Draft registration statement
12:00am
- Prev
- 1
- Next